26th April 2021, New Delhi: The Indias3n Institute of Technology-Kanpur (IIT-K) has collaborated with I2Cure (P) Ltd, a ‘Make in India for the world’ Biotech company for all future research on Molecular iodine-based products that would be undertaken by the Biological Sciences & Bioengineering wing of IIT-K .
Under the terms of the agreement, I2Cure future products would be incubated at IIT-Kanpur. The relationship would be of the equity partners, and validations of Dr. Jack Kessler’s global research would be done for Indian conditions at IIT-K. IIT-K would also work with I2Cure to develop new ‘Made in India’ products for global markets, especially in tackling long-term problems in the space of Human Preventive Health, Veterinary science (FMD, Bovine Mastitis, Dermatitis), and Agri products.
Stating on this momentous occasion, Mr. Anil Kejriwal, Founder Chairman of I2Cure shared, “I am delighted to partner my alma mater, IIT-Kanpur for research and innovation on future-ready preventive & curative products. It gives us great pleasure to be associated with an institution that is regarded as the gold standard among IITs We would jointly be happy to contribute towards the vision of the Hon’ble Prime Minister of India to double Agricultural income as well as become a $5 Trillion economy.
